Carmel, IN, United States of America

Virender Kumar Sarin

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Virender Kumar Sarin. Retrieved from https://idiyas.com/inventor/virender-kumar-sarin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 71.4


 

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 151(Granted Patents)


Company Filing History:


Years Active: 2006-2026

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Virender Kumar Sarin

Introduction

Virender Kumar Sarin is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of insulin formulations, holding a total of six patents. His work focuses on improving the pharmacokinetic and pharmacodynamic properties of insulin, which is crucial for diabetes management.

Latest Patents

Among his latest patents is a composition of rapid-acting insulin that includes specific concentrations of citrate and chloride. This innovative formulation may also incorporate sodium chloride, zinc, and optionally magnesium chloride and/or surfactant. The goal of this invention is to achieve faster action compared to existing commercial insulin analog products.

Career Highlights

Virender Kumar Sarin is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its advancements in diabetes care. His work at Eli Lilly has positioned him as a key player in the development of new insulin therapies.

Collaborations

He has collaborated with notable colleagues such as Michael Patrick Akers and Chi Arch Nguyen, contributing to a dynamic research environment that fosters innovation.

Conclusion

Virender Kumar Sarin's contributions to insulin formulations exemplify the impact of innovative thinking in the pharmaceutical industry. His patents reflect a commitment to enhancing diabetes treatment options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…